Evidence map›Paper›PMID 33364236›Full record

ArticleFrontiers in cell and developmental biology2020

Long Non-coding RNA X-Inactive Specific Transcript Mediates Cell Proliferation and Intrusion by Modulating the miR-497/Bcl-w Axis in Extranodal Natural Killer/T-cell Lymphoma.

Qinhua Liu, Ruonan Ran, Zhengsheng Wu, Xiaodan Li, Qingshu Zeng, Ruixiang Xia, Yalei Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Frontiers in immunology · 2026
    Article
  2. Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Qinhua LiuDepartment of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ruonan RanDepartment of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhengsheng WuDepartment of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xiaodan LiDepartment of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Qingshu ZengDepartment of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ruixiang XiaDepartment of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yalei WangDepartment of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
First Affiliated Hospital of Anhui Medical University · CNAnhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was directed toward laying new findings for Extranodal natural killer/T-cell lymphoma (ENKL)-oriented therapy with a focus on long non-coding RNA (lncRNA)-microRNAs (miRNAs)-mRNA interaction. The expression and function of XIST (X-inactive specific transcript) were analyzed both

Indexed as

ENKLlncRNAmigrationmiRNAproliferation

Identifiers

PMID33364236
PMCPMC7753184
OpenAlexW3113161368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.